Search Ontology:
ChEBI
1-palmitoyl-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycero-3-phosphoethanolamine
- Term ID
- CHEBI:84549
- Synonyms
-
- (19R)-25-amino-22-hydroxy-22-oxido-16-oxo-17,21,23-trioxa-22lambda(5)-phosphapentacosan-19-yl (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate
- 1-hexadecanoyl-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycero-3-phosphoethanolamine
- 1-Palmitoyl-2-adrenoyl-sn-glycero-3-phosphoethanolamine
- GPEtn(16:0/22:4)
- GPEtn(16:0/22:4n6)
- GPEtn(16:0/22:4w6)
- PE(16:0/22:4(7Z,10Z,13Z,16Z))
- PE(16:0/22:4)
- PE(16:0/22:4n6)
- PE(16:0/22:4w6)
- Phophatidylethanolamine(16:0/22:4n6)
- Phophatidylethanolamine(16:0/22:4w6)
- Definition
- A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups specified at position 1 and 2 are palmitoyl and (7Z,10Z,13Z,16Z)-docosatetraenoyl respectively.
- References
-
- HMDB:HMDB0008943
- LIPID_MAPS_instance:LMGP02010116
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_functional_parent
-
- has_role
-
Show first 5 Terms
Phenotype
Phenotype resulting from 1-palmitoyl-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycero-3-phosphoethanolamine
Phenotype where environments contain 1-palmitoyl-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycero-3-phosphoethanolamine
Phenotype modified by environments containing 1-palmitoyl-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycero-3-phosphoethanolamine
Human Disease Model